Comorbidities may offset expected improved survival after transcatheter aortic valve replacement.

ABSTRACT:

Aims

After transcatheter aortic valve replacement (TAVR), cardiovascular and non-cardiovascular comorbidities may offset the survival benefit from the procedure. We aimed to describe the relationships between that benefit and patient comorbidities.

Methods and results

The study pooled two European cohorts of patients with severe aortic stenosis (AS-pooled): one with patients who underwent (cohort of AS patients treated by TAVR, N = 233) and another with patients who did not undergo TAVR (cohort of AS patients treated medically; N = 291). The investigators collected the following: calcification prognostic impact (CAPRI) and Charlson scores for cardiovascular and non-cardiovascular comorbidities, activities of daily living (ADL)/instrumental activities of daily l

SUBMITTER: Lantelme P 

PROVIDER: S-EPMC9242031 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature